Insulinoma Masquerading as Epilepsy: Diagnosis by Endoscopic Ultrasound (EUS)
Keywords:
insulinoma, hypoglycemia, endoscopic ultrasound, neuroendocrine tumor, seizuresAbstract
Insulinoma is a rare functional neuroendocrine neoplasm that causes hypoglycemia secondary to inappropriate insulin secretion. Its clinical presentation may mimic neurological disorders, often leading to delayed diagnosis. Methods: We report a case of insulinoma diagnosed by endoscopic ultrasound (EUS), accompanied by a narrative review of the recent literature. Results: A 28-year-old male presented with a history of recurrent seizure episodes for approximately ten years and had been treated as having epilepsy without adequate therapeutic response. During one episode, severe hypoglycemia was documented, fulfilling Whipple’s triad. Conventional imaging studies, including computed tomography and magnetic resonance imaging, failed to identify the lesion. Subsequently, EUS revealed a 25 × 20 mm hypoechoic mass located in the pancreatic tail. Fine-needle biopsy confirmed a well-differentiated grade 1 neuroendocrine tumor. The patient underwent distal pancreatectomy with complete resolution of symptoms. Conclusion: Insulinoma should be considered in the differential diagnosis of patients with atypical or difficult-to-control seizures. EUS is a highly sensitive tool for tumor localization, particularly in cases with negative conventional imaging studies.
References
1. Zhuo F, Menon G, Anastasopoulou C. Insulinoma. StatPearls Publishing; 2025.
2. Qu YQ, Wang D, Sun ZQ, et al. Insulinoma misdiagnosed as epilepsy in 44 Chinese patients. Chin Med J (Engl). 2021;134(15):1852-1854.
3. Wang H, Ba Y, Xing Q, Du J. Diagnostic value of endoscopic ultrasound for insulinoma localization: a systematic review and meta-analysis. PLoS One. 2018;13(10): e0206099.
4. Hofland J, Refardt JC, Feelders RA, Christ E, de Herder WW. Approach to the Patient: Insulinoma. J Clin Endocrinol Metab. 2024 Mar 15;109(4):1109-1118.
5. Castro-Gómez KG, Contreras-Romero JA, Afanador Jaimes DV, Álvarez Herrera LV, Gaitán Díaz NL, Saavedra-López HF. Approaching insulinoma: an updated review of the literature. Rev Colomb Endocrinol Diabet Metab. 2024;11(1):e822.
6. Wiese D, Humburg FG, Kann PH, Rinke A, Luster M, Mahnken A, Bartsch DK. Changes in diagnosis and operative treatment of insulinoma over two decades. Langenbecks Arch Surg. 2023 Jun 29;408(1):255.
7. de Carbonnières A, Challine A, Cottereau AS, Coriat R, Soyer P, Abou Ali E, Prat F, Terris B, Bertherat J, Dousset B, Gaujoux S. Surgical management of insulinoma over three decades. HPB (Oxford). 2021 Dec;23(12):1799-1806.
8. Dhar J, Thompson CC. Endoscopic ultrasound-guided radiofrequency ablation of insulinoma: current status and future perspectives. Expert Opin Ther Targets. 2024;28(4):287-296.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista Dominicana de Gastroenterología

This work is licensed under a Creative Commons Attribution 4.0 International License.